Dr. Ali W. Bseiso
Claim this profileMarshfield Medical Center-Marshfield
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
8 reported clinical trials
28 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
FLT3 positive
BCR-ABL1 positive
t(8;21) negative
2Myeloid Leukemia
FLT3 positive
t(8;21) negative
inv(16) negative
Affiliated Hospitals
Clinical Trials Ali W. Bseiso is currently running
Venetoclax + HMA
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach.
Recruiting1 award Phase 27 criteria
Pembrolizumab + TKI
for Chronic Myeloid Leukemia
This phase II trial studies how well pembrolizumab and dasatinib, imatinib mesylate, or nilotinib work in treating patients with chronic myeloid leukemia and persistent detection of minimal residual disease, defined as the levels of a gene product called bcr-abl in the blood. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Dasatinib, imatinib mesylate, and nilotinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving pembrolizumab and dasatinib, imatinib mesylate, or nilotinib may work better in treating patients with chronic myeloid leukemia.
Recruiting1 award Phase 2
More about Ali W. Bseiso
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Ali W. Bseiso has experience with
- Lenalidomide
- Dexamethasone
- Gilteritinib
- Cytarabine
- Dasatinib
- Blinatumomab
Breakdown of trials Ali W. Bseiso has run
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Acute Myeloid Leukemia
Cancer
Chronic Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ali W. Bseiso specialize in?
Ali W. Bseiso focuses on T-Lymphoblastic Leukemia/Lymphoma and Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved FLT3 positive patients, or patients who are BCR-ABL1 positive.
Is Ali W. Bseiso currently recruiting for clinical trials?
Yes, Ali W. Bseiso is currently recruiting for 6 clinical trials in Marshfield Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Ali W. Bseiso has studied deeply?
Yes, Ali W. Bseiso has studied treatments such as Lenalidomide, Dexamethasone, Gilteritinib.
What is the best way to schedule an appointment with Ali W. Bseiso?
Apply for one of the trials that Ali W. Bseiso is conducting.
What is the office address of Ali W. Bseiso?
The office of Ali W. Bseiso is located at: Marshfield Medical Center-Marshfield, Marshfield, Wisconsin 54449 United States. This is the address for their practice at the Marshfield Medical Center-Marshfield.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.